Navigation Links
Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
Date:2/5/2008

December 29, December 31,

2007 2006 2007 2006

Tax

benefit

on a

GAAP

basis $1,162 46.4% $826 36.7% $893 38.1% $1,463 58.3%

Amortization

of

purchased

intan-

gibles (1,375) (1,289) (5,033) (4,822)

Litigation

/make-

whole

provision (2) (11) 33 (179)

CEO

transition

costs

and other - (47) - (456)

Share-

based

compen-

sation

expense (2,107) (333) (3,510) (1,752)

In-

process

research

and

develop-

ment - (448) - (448)

Tax expense

on a

non-GAAP

basis $(2,322) -26.0% $(1,302) -15.2% $(7,617) -29.0% $(6,194) -23.2%

The following tables reconcile the Guidance on a GAAP and Non-GAAP basis for the periods shown below:

THORATEC CORPORATION

Reconciliation of GAAP to Non-GAAP Forward-Looking Guidance

(Unaudited)

(in thousands, except for per share data)

Gross margin For the Fiscal

Year Ended 2008

From To

(in thousands)

Gross profit on a GAAP basis 58% 59%

Share-based compensation expense:

- Cost of product sales 1% 1%

Gross profit on a non-GAAP basis 59% 60%

Operating Income For the Fiscal'/>"/>

SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Thoratec Presentation at JP Morgan Conference to be Webcast
2. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
3. Thoratec Presentation at Bear Stearns Conference To Be Webcast
4. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
5. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
6. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
7. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
8. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
9. Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination
10. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
11. Millennium Biotechnologies Group Reports 40% Sales Increase for Resurgex Product Line in Greek Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the ... results for the six months ended June 30, ... Canadian dollars and presented under International Financial Reporting ... , Announced top-line results related to ... for subjects enrolled in the Phase 2 iDEAL ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Local veterinarian, ... Veterinary Hospital are seeking candidates to participate in an ... osteoarthritis. The ultimate goal of this study is ... cells into one or two arthritically affected joints can ... , Candidates for the current investigational study must ...
(Date:8/29/2014)... California (PRWEB) August 29, 2014 ... of Energy's 2014 Hydrogen Production R&D Award ... -- by splitting water using sunlight. , Shared ... (NREL) and the University of Nevada, Las Vegas ... work developing models of photoelectrochemical solar-hydrogen production and ...
(Date:8/29/2014)... August 29, 2014 Due to a misstatement ... week, the Adult Stem Cell Technology Center, LLC ( ASCTC ... stem cell therapy research that might benefit ALS patients. ... for new stem cell technologies and therapeutic applications, FRC listed ... Bucket Challenge donors who wish not to support research ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2Livermore Team Awarded for Hydrogen Production Research 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3
... Biotechnologies, LLC,an early stage biotechnology company developing ... that the company will,deliver a presentation at ... Jeffrey C. Travis, Ph.D., Maven,s President and ... at 3:30 PM. About Maven Biotechnologies ...
... ... Community, NEW ... Cancer Awareness Month, Answers.com,s question and answer community,WikiAnswers(TM), is spotlighting its ... family have gathered to ask questions and share their personal,experiences and ...
... One Deserving Facility Win Needed Medical ... MALVERN, Pa., Oct. 22 Television medical dramas such ... in hospitals,across the country to millions of Americans each week. ... resonance imaging,(MRI) system - are being given the opportunity to ...
Cached Biology Technology:Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference 2Answers.com's WikiAnswers Supervisors Rallying for National Breast Cancer Awareness Month 2Answers.com's WikiAnswers Supervisors Rallying for National Breast Cancer Awareness Month 3American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 2American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 3
(Date:8/28/2014)... app called TX Invasives is now available from the ... Texas at Austin for identifying harmful non-native plant, insect ... in the United States cause about $137 billion in ... crops, clog waterways, kill native plants and more. , ... for reporting where invasive species occur, we,re more likely ...
(Date:8/28/2014)... America (ESA) is pleased to announce the selection of ... Society. Honorary Membership acknowledges those who have served ESA ... the affairs of the Society that has reached an ... the ESA Governing Board and then voted on by ... the Awards Ceremony at Entomology 2014, ESA,s Annual Meeting ...
(Date:8/28/2014)... researchers have identified a handful of bacterial culprits that ... disease and ulcerative colitis, using patients, own intestinal immune ... Aug. 28 in the journal Cell . , ... which plays a critical role in the development and ... small number of bacterial species affect a person,s susceptibility ...
Breaking Biology News(10 mins):Mobile app makes ID of harmful plants, insects in Texas a snap 2Fred Baxendale selected as Honorary Member of the Entomological Society of America 2Yale study identifies possible bacterial drivers of IBD 2
... along with senior author Henri Tiedge, PhD, professor of ... suggesting that cellular dysregulation associated with certain neurodegenerative disorders ... pathways. The paper appeared in the ... in Neuronal RNA Targeting: Role of RNA-hnRNP A2 Interactions." ...
... long-sought new way to detect the activity of proteins that ... of genes in ways that make cells do everything from ... Journal of the American Chemical Society . ... 10 percent of the 25,000-30,000 genes in the human body ...
... German . Oxygen-consuming organisms obtain energy ... and oxygen into carbon dioxide and water. This process ... immediately, as they would otherwise cause damage to cells. ... in Berlin have now discovered a mechanism, with whose ...
Cached Biology News:Researchers publish study on neuronal RNA targeting 2Cellular metabolism self-adapts to protect against free radicals 2
Includes USB cable, custom driver and one roll of thermal paper...
Mycoplasma and virus tested...
... 10X BlueJuice Gel Loading ... easy loading and tracking ... agarose or native polyacrylamide ... features higher density sucrose ...
Ready-to-use solution....
Biology Products: